Persion Pharmaceuticals

Persion Pharmaceuticals is a U.S.-focused specialty pharmaceutical company that acquires, develops, and commercializes prescription medicines for chronic pain. The company presents itself as dedicated to patients living with chronic pain and emphasizes acquisition, in-licensing, development, integration, and commercialization of specialty pharmaceutical products. Its publicly identified commercial product is Zohydro ER, an extended-release hydrocodone product used for chronic pain management. Persion appears to operate as a private company and is part of the Currax Holdings organization, with a corporate headquarters in Brentwood, Tennessee. The company’s business development strategy includes pursuing growth through both organic initiatives and strategic inorganic expansion.